Drug Effects on Mood and Behavior - Expectancy
NCT07061886 · MESA-X · University of Chicago
What it is testing
Summary
Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.
What counts as success
Primary outcome measures
Visual Analog Scale (VAS)
Measured over During in-lab session: Pre-drug, and every 60 minutes post-drug from 0-4 hours
Addiction Research Center Inventory (ARCI)
Measured over During in-lab session: Pre-drug, and every 60 minutes post-drug from 0-4 hours
Drug Effects Questionnaire (DEQ)
Measured over During in-lab session: Pre-drug, and every 60 minutes post-drug from 0-4 hours
5 Dimensions of Altered States of Consciousness (5D-ASC) scale
Measured over End of session (4 hours post-drug)
Ultimatum Game
Measured over During in lab session: 1.5 hours post-drug
A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.
Who can take part
Eligibility, as published
Where
1 study site
| Facility | City | Region | Country |
|---|---|---|---|
| University of Chicago | Chicago | Illinois | United States |
On the registry
Contact the trial directly
This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.
Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.
NCT07061886 on ClinicalTrials.gov →
Last updated in the registry 2026-07-09. Registry records change; this page reflects the data build of 2026-08-25.
Related
Where this trial sits
Substance
Recruiting in